患者报告结局能否替代门诊随访记录乳腺癌放疗晚期结局?十年随访比较
该研究比较乳腺癌辅助放疗后10–11年门诊晚期结局随访(OCLO)与患者报告结局(PROMs)的晚期毒性记录,249例到访OCLO、341例返回问卷。群体水平患者报告毒性率高于医生,个体一致率平均58%,2.8%医生报告毒性高≥2度、6.8%患者报告高≥2度。结论认为PROMs在群体水平不低估晚期副作用,尽管一致率低,仍可用于识别副作用负担重的患者,从而省去OCLO到访。
要点
- 群体水平患者报告晚期毒性率高于医生报告。
- 个体患者与医生报告结局平均一致率为58%。
- PROMs可用于识别副作用负担重、需特别关注的患者。
核心结论
- PROMs在群体水平不低估晚期副作用。
- 尽管一致率低,PROMs可用于识别副作用负担重的患者,从而省去OCLO到访。
研究设计与样本
- 邀请10–11年前在本机构接受辅助放疗的乳腺癌患者到访OCLO并填写PROM问卷。
- 1029例中686例仍存活,249例到访OCLO,341例返回问卷。
主要发现
- 群体水平患者报告的毒性率高于医生报告。
- 个体患者与医生报告结局平均一致率为58%。
- 2.8%的病例医生报告毒性比患者高≥2度,6.8%的病例患者报告毒性比医生高≥2度。
临床怎么用
- 可考虑用PROMs替代OCLO到访以识别晚期副作用负担重的乳腺癌放疗患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate whether breast cancer patients' visits to an outpatient clinic for late outcome (OCLO) can be replaced by patient reported outcome measures (PROMs), by comparing late toxicity scored at the OCLO with PROMs. METHODS: All breast cancer patients treated in our institute with adjuvant radiotherapy 10-11years ago were invited to visit the OCLO, and for filling out PROM-questionnaires. Concordance rate between PROMs and OCLO-reported outcome and the percentage of patients with ≥2 degrees difference in toxicity level between patient and clinician was assessed. RESULTS: 686 of 1029 patients were still alive. 249 patients visited the OCLO, and 341 patients returned a questionnaire. At a group level, patients reported higher toxicity rates than clinicians. The mean concordance for individual patients was 58% between patient and clinician reported outcome. In 2.8%, the clinician reported ≥2 degrees higher toxicity than the patients did, whereas in 6.8% patients reported ≥2 degrees higher toxicity. CONCLUSION: PROMs do not underestimate late side-effects at a group level. In spite of the low concordance rate, PROMS can be used to identify patients who experience a heavy burden of side-effects, requiring specific attention. Therefore, patients can be spared a visit to the OCLO.
引用
- Brouwers PJAM, van Loon J, Houben RMA, et al. Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow up. Radiother Oncol. 2017. PMID: 28844787. doi:10.1016/j.radonc.2017.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。